- 17 April 2007 -

GE Healthcare develops biopharm segment with new purchase

GE Healthcare has acquired Wave Biotech LLC, a supplier of disposable manufacturing technologies for the biopharmaceutical industry.

GE says that the acquisition of Wave Biotech LLC, including its subsidiary Wave Europe Pvt. Ltd, will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as antibodies and vaccines. Wave Biotech develops and manufactures bioreactors designed to replace stainless steel tanks and piping by eliminating the need for cleaning and validating between batches.

"Our customers will benefit greatly from the global presence and the R&D resources that GE Healthcare brings to the table," said Dr. Vijay Singh, President and founder of Wave Biotech. "The integration of single-use cell culture with GE Healthcare's existing filtration and downstream operations will provide a host of new disposable solutions to this growing industry."

www.gehealthcare.com